Showing results (261-270 of 294) with videos related to
Sort By:
Pageof 30
The New England Journal of Medicine|December 7, 2000
Peginterferon alfa-2a in patients with chronic hepatitis CS Zeuzem, S V Feinman, J Rasenack, et al.Ultraschall in Der Medizin (Stuttgart, Germany : 1980)|June 14, 2011
Differentiation between benign and malignant adrenal mass using contrast-enhanced ultrasoundM Friedrich-Rust, T Glasemann, A Polta, et al.Hepatology (Baltimore, Md.)|March 30, 1999
A phase I/II study of recombinant human interleukin-12 in patients with chronic hepatitis CS Zeuzem, U Hopf, V Carreno, et al.Journal of Hepatology|March 1, 2011
IL28B polymorphisms predict reduction of HCV RNA from the first day of therapy in chronic hepatitis CP-Y Bochud, S Bibert, F Negro, et al.Journal of Viral Hepatitis|October 10, 2012
Optimized threshold for serum HCV RNA to predict treatment outcomes in hepatitis C patients receiving peginterferon alfa-2a/ribavirinS Zeuzem, M Rodríguez-Torres, K Rajender Reddy, et al.Vaccine|June 28, 2008
Cross-genotype-reactivity of the immunodominant HCV CD8 T-cell epitope NS3-1073P Fytili, G N Dalekos, V Schlaphoff, et al.Journal of Viral Hepatitis|May 11, 2012
Renal function during treatment with adefovir plus peginterferon alfa-2a vs either drug alone in hepatitis B/D co-infectionI Mederacke, C Yurdaydin, A Großhennig, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 19, 2007
Second-line chemotherapy with pemetrexed after gemcitabine failure in patients with advanced pancreatic cancer: a multicenter phase II trialS Boeck, K Weigang-Köhler, M Fuchs, et al.Zeitschrift Fur Gastroenterologie|June 18, 2009
The German Hep-Net acute hepatitis C cohort: impact of viral and host factors on the initial presentation of acute hepatitis C virus infectionK Deterding, J Wiegand, N Grüner, et al.Journal of Hepatology|September 16, 2003
Randomized, controlled trial with IFN-alpha combined with ribavirin with and without amantadine sulphate in non-responders with chronic hepatitis CGerlinde Teuber, M Pascu, T Berg, et al.Pageof 30